Related Experiment Videos
Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components
Bertrand Actor1, J M J Ludwig Cobbers, Rainer Büschges
1Abteilung Molekulare Genetik, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
Genes, Chromosomes & Cancer
|July 12, 2002
Summary
Gliosarcomas share genomic alterations with glioblastomas but exhibit greater genomic stability. These findings support a single precursor cell origin for both tumor components, with specific gene amplifications potentially driving sarcomatous development.
Area of Science:
- Neuro-oncology
- Cancer Genomics
- Molecular Pathology
Background:
- Gliosarcoma, a glioblastoma variant, presents dual gliomatous and sarcomatous differentiation.
- Understanding its genetic landscape is crucial for distinguishing it from glioblastoma.
Purpose of the Study:
- To investigate genetic aberrations in gliosarcomas.
- To compare the genomic profile of gliosarcomas with glioblastomas.
- To explore the clonal origin of gliosarcoma components.
Main Methods:
- Comparative genomic hybridization (CGH) on 38 gliosarcomas.
- Analysis of tumor-suppressor genes and proto-oncogenes (e.g., TP53, PTEN, CDK4, MDM2, EGFR, PDGFRA).
- Microdissection and DNA amplification for component-specific CGH.
Main Results:
- Gliosarcomas exhibit genetic alterations similar to glioblastomas, including EGFR, PDGFRA, CDK4, and MDM2 amplifications, and TP53/PTEN mutations.
- Common chromosomal imbalances include gains on chromosome 7 and losses on chromosome 10.
- Both gliomatous and sarcomatous components share a significant portion of chromosomal imbalances, suggesting a common origin.
Conclusions:
- Gliosarcomas share genomic similarities with glioblastomas but possess higher genomic stability.
- Evidence supports a single precursor cell origin for both gliosarcoma components.
- Amplification of genes on proximal 12q may contribute to the sarcomatous phenotype.